Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Februar 2015 08:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentation at Cowen and Company's 35th Annual Health Care Conference

CAMBRIDGE, Mass., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
17. Februar 2015 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results

CAMBRIDGE, Mass., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the fourth quarter and year ended December 31, 2014. For the...
03. Februar 2015 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
29. Januar 2015 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
21. Januar 2015 08:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Supreme Court Decision to Remand Generic Copaxone(R) Case Back to CAFC

CAMBRIDGE, Mass., Jan. 21, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today announced that the United States Supreme Court has vacated the 2013 decision of the Court of...
01. Dezember 2014 08:15 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals' Necuparanib Receives Fast Track Designation From the FDA for the Treatment of Patients With Metastatic Pancreatic Cancer

CAMBRIDGE, Mass., Dec. 1, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
01. Dezember 2014 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Acceptance of a Clinical Trial Application in Europe for M923, a Biosimilar Version of Humira(R)

CAMBRIDGE, Mass., Dec. 1, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
24. November 2014 16:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentation at 2014 Deutsche Bank BioFEST

CAMBRIDGE, Mass., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
06. November 2014 08:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 6, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
05. November 2014 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Third Quarter 2014 Financial Results

CAMBRIDGE, Mass., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...

Vorherige Seite

Nächste Seite